Neogenomics Inc (NASDAQ:NEO)

9.27
Delayed Data
As of Apr 20
 +0.05 / +0.54%
Today’s Change
7.08
Today|||52-Week Range
11.63
+4.63%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close9.22
Today’s open9.19
Day’s range9.08 - 9.49
Volume287,712
Average volume (3 months)362,430
Market cap$700.4M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+64.10%
Earnings growth (this year)+32.48%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+5.95%
P/E ratioNM
Price/Sales2.72
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NTRANatera Inc-0.13-1.17%
KANGiKang Healthcare Gro...+0.11+0.55%
ENZEnzo Biochem Inc-0.01-0.16%
GHDXGenomic Health Inc+0.03+0.09%
Data as of 4:02pm ET, 04/20/2018

Financials

Next reporting dateMay 1, 2018
EPS forecast (this quarter)$0.04
Annual revenue (last year)$258.6M
Annual profit (last year)-$846.0K
Net profit margin-0.33%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Chief Scientific Officer &
VP-Operations
Steven G. Brodie
Corporate headquarters
Fort Myers, Florida

Forecasts